UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites ▲ | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A9D2YNQ8 | Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
|
1 | 0 |
|
A0A8C6NPN2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6L9P9 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A1A8VEA7 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A8C6NSV5 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
A0A8C6NIL2 | Voltage-dependent T-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A1A8UDM6 | Ret proto-oncogene receptor tyrosine kinase (Fragment) |
|
1 | 0 |
|
A0A9D2YLR7 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
A0A8C6KL39 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A1A8VKY7 | GDNF family receptor alpha |
|
1 | 0 |
|
A0A1A8AEN0 | Hyaluronidase |
|
1 | 0 |
|
A0A1A8AC29 | Hyaluronidase |
|
1 | 0 |
|
A0A9D2YHY6 | Voltage-dependent T-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A9D3BZF8 | Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
|
1 | 0 |
|
A0A9D2YQA2 | Pannexin |
|
1 | 0 |
|
A0A8C6Q6P5 | P2X purinoceptor |
|
1 | 0 |
|
A0A8C6MGE0 | P2X purinoceptor |
|
1 | 0 |
|
A0A1A7ZF41 | P2X purinoceptor |
|
1 | 0 |
|
A0A1A7ZKM3 | Ret proto-oncogene receptor tyrosine kinase (Fragment) |
|
1 | 0 |
|
A0A9D3BEY3 | Pannexin |
|
1 | 0 |
|
A0A9D2YK30 | Voltage-dependent T-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A9D2Y0D4 | N-acetylgalactosamine-6-sulfatase |
|
1 | 0 |
|
A0A8C6KP52 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A9D2YNI7 | Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
|
1 | 0 |
|
A0A8C6VWP0 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024